Onyx Pharmaceuticals Profile

Onyx Pharmaceuticals Patent Grants

Compositions and methods for treating psoriasis

Patent Number 9636321 - May 2, 2017

Novel isohexides and pharmaceutical compositions containing the same as well as methods of using the same in the treatment of psoriasis.

Synthesis of cyclopentaquinazolines

Patent Number 8809526 - August 19, 2014

A method of producing 6-amino-cyclopenta[g]quinazolines, in enantiomerically enriched form, is provided. In particular, the method may be…

Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase

Patent Number 7994294 - August 9, 2011

The present invention relates to all aspects of a guanine exchange factor (GEF), for example, a Rho-GEF, such as p115 Rho-GEF. A GEF modulates…

Adenoviral vectors for treating disease

Patent Number 7829329 - November 9, 2010

Adenoviral vectors, including mutant adenoviruses, that have restriction sites in the E3 region, that facilitate its partial or total…

Adenovirus E1B-55K single amino acid mutants and methods of use

Patent Number 7785887 - August 31, 2010

Adenoviral mutants are described that have single amino acid mutations in the E1B-55K protein which mutations effect the p53…

Onyx Pharmaceuticals Patent Applications

Synthesis of Cyclopentaquinazolines

Application Number 20130211082 - August 15, 2013

A method of producing 6-amino-cyclopenta[g]quinazolines, in enantiomerically enriched form, is provided. In particular, the method may be…

Compounds For Enzyme Inhibition

Application Number 20120277146 - November 1, 2012

Peptide-based compounds including heteroatom-containing, three-membered rings efficiently and selectively inhibit specific activities of…

Pharmaceutical compositions comprising anti-inflammatory quinazolinecarboxamide derivatives

Application Number 20070191400 - August 16, 2007

The present invention provides pharmaceutical compositions comprising quinazolinecarboxamide derivative, and certain novel…

Screening of anti-viral drugs and pharmaceuticals composition containing thiazolidinone derivatives

Application Number 20070179137 - August 2, 2007

The present invention relates to a method of screening for small organic molecules that directly inhibit the interaction of glycosaminoglycans…

Candida Kefyr Cytosine Deaminase

Application Number 20070026491 - February 1, 2007

A new cytosine deaminase gene and protein from Candida kefyr are provided. This protein has increased ability to convert the 5-fluorocytosine…

Onyx Pharmaceuticals Federal District Court Decisions

Bayer HealthCare LLC et al v. Mylan Pharmaceuticals Inc.

Delaware District Court - March 30, 2016

MEMORANDUM ORDER re (12 in 1:15-cv-00114-LPS)(9 in 1:15-cv-01162-LPS) MOTIONS to Dismiss are DENIED without prejudice to renew. Signed…

Securities and Exchange Commission v. One Or More Unknown Traders In The Securities Of Onyx Pharmaceuticals, Inc.

New York Southern District Court - September 29, 2014

OPINION AND ORDER re: 51 MOTION to Dismiss the Amended Complaint and to Vacate the July 10, 2013 Order Freezing Assets, filed by Dhia …

Onyx Pharmaceuticals, Inc. v. Bayer Corporation et al

California Northern District Court - May 10, 2011

ORDER GRANTING 139 Administrative Motion to File Under Seal Confidential Documents Cited in Bayer's Motion in Limine filed by Bayer…

Onyx Pharmaceuticals, Inc. v. Bayer Corporation et al

California Northern District Court - February 2, 2011

STIPULATION AND ORDER modifying briefing schedules re summary judgment motions; Signed by Judge Marilyn Hall Patel on 2/2/2011. (awb, COURT…

Onyx Pharmaceuticals, Inc. v. Bayer Corporation et al

California Northern District Court - June 22, 2010

STIPULATION AND ORDER: Further Case Management Conference continued to 8/2/2010 03:00 PM in Courtroom 15, 18th Floor, San Francisco; Signed by…

Onyx Pharmaceuticals State Court Decisions

Securities and Exchange Commission v. One Or More Unknown Traders In The Securities Of Onyx Pharmaceuticals, Inc.

New York New York Southern District Court - June 8, 2015

OPINION AND ORDER re: 91 MOTION for Reconsideration of the Court's September 29, 2014 Opinion and Order filed by Dhia Jafar, Omar…

Securities and Exchange Commission v. One Or More Unknown Traders In The Securities Of Onyx Pharmaceuticals, Inc.

U.S. District Court for the Southern District of New York - September 29, 2014

OPINION AND ORDER re: 51 MOTION to Dismiss the Amended Complaint and to Vacate the July 10, 2013 Order Freezing Assets, filed by Dhia Jafar,…